+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Counting Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 333 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5934485
The global cell counting market is poised for substantial growth during forecast period 2024 to 2031. As of 2024, the market is estimated to reach a valuation of US$19 Billion, a significant increase from US$9 Billion in 2024. The escalating prevalence of infectious and chronic diseases worldwide, coupled with advancements in cell counting technology, is fueling this impressive growth.

Factors Propelling the Global Cell Counting Market

The COVID-19 pandemic had a profound impact on the global cell counting market, with increased demand for cell counting technology to detect infections and monitor health conditions. The pandemic highlighted the importance of cell counting in diagnosing diseases like COVID-19, osteopenia, and lymphopenia. Consequently, it played a pivotal role in shaping the market's trends and opportunities.

The growing utilization of cell counting equipment and supplies across various sectors, including research, healthcare, and industrial applications, is a key driver of market growth. Electronic cell counting devices are increasingly being used in fields such as cancer biology, immunology, and neurology, offering exponential growth prospects.

Biotechnology and pharmaceutical industries are expected to experience significant growth, further boosting the demand for cell counting. Government initiatives to support cell therapy research and increased funding for stem cell research in multiple countries are expediting market growth.

Prevailing Opportunities in the Global Cell Counting Market

The rising incidence of infectious and chronic diseases, technical advancements, and new product releases are expected to propel the global cell counting market. Automated cell counters have made it easier to determine stem cell viability and nucleated cell content, offering lucrative opportunities for both existing and new healthcare equipment manufacturers.

The introduction of innovative products, such as reusable 3D cell culture microplates, is expected to stimulate market growth. Researchers can use these plates to create embryoid bodies, a crucial step in developing larger organoids or spheroids from stem cells.

Factors Hampering the Global Cell Counting Market

The high cost of hemocytometers and disposable cell counters is anticipated to limit market opportunities. Additionally, the elevated prices of sophisticated cell counting methods and product recalls related to hematology analyzers may restrain market trends.

Production and sourcing constraints in the bioprocessing of biologics using cell counting techniques could pose a significant challenge to adoption in the coming years.

Dominating Market Segments

In the component segment, consumables and accessories contribute over 50% of the total revenue, with reagents, microplates, instruments, magnetic beads, and chamber slides being the highest contributing sub-segments. The instruments section is also expected to maintain a significant share in terms of value.

Leading Market Segments by Application

The whole blood count segment holds the highest share, with over 55% of total revenue generated annually. The need to monitor various blood components in the context of blood illnesses like leukemia and anemia drives the growth of this segment.

The stem cell research application segment is projected to exhibit the fastest CAGR during the forecast period, driven by the increasing demand for stem cells in transplantation, cancer treatment, and tissue regeneration.

Country-wise Insights

United States: North America dominates the global cell counting market, with the United States leading in sales and usage of cell counting machines. Factors such as a growing incidence of chronic diseases, blood plasma disorders, and cardiovascular conditions contribute to the market's expansion.

Europe: The robust healthcare infrastructure in major European economies and a growing elderly population drive demand for cell counting technology. The UK is expected to be a lucrative market in the region.

South Korea: Increasing clinical research and biopharmaceutical businesses in the Asia-Pacific region boost domestic demand for cell counting devices, providing growth opportunities in the South Korean market.

Japan: Japan's role as a manufacturing and exporting hub for electronic equipment has created opportunities for regional market players, particularly in exporting cell counting devices.

Competitive Landscape

Key players in the global cell counting market include:

  • ThermoFisher Scientific, Inc.
  • Merck KGaA
  • Agilent Technologies
  • PerkinElmer, Inc.
  • BD
  • Danaher
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • GE Healthcare
  • DeNovix Inc.
The growing popularity of electronic cell counters, such as the countess automated cell counter, is expected to strengthen market growth. Technical advancements in equipment and consumables have driven product introductions and market expansion.

Key Segments Covered in the Global Cell Counting Industry Report

Global Cell Counting Market by Product

  • Cell Counting Instruments
  • Spectrophotometers
  • Flow Cytometers
  • Hemocytometers
  • Automated Cell Counters
  • Microscopes
  • Others
  • Cell Counting Consumables & Accessories
  • Reagents
  • Microplates
  • Others

Global Cell Counting Market by Application

  • Cell Counting for Complete Blood Count
  • Automated Cell Counters
  • Manual Cell Counters
  • Cell Counting for Stem Cell Research
  • Cell Counting for Cell Based Therapeutics
  • Cell Counting for Bioprocessing
  • Cell Counting for Toxicology
  • Others

Global Cell Counting by End User

  • Global Cell Counting in Hospitals & Diagnostic Laboratories
  • Global Cell Counting in Research & Academic Institutes
  • Global Cell Counting in Pharmaceutical & Biotechnology Companies
  • Others

Global Cell Counting Market by Region

  • North America Cell Counting Market
  • Europe Cell Counting Market
  • Asia-Pacific Cell Counting Market
  • Middle East & Africa Cell Counting Market
  • South America Cell Counting Market


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Cell Counting Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Cell Counting Market Outlook, 2018 - 2031
3.1. Global Cell Counting Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Cell Counting Instruments
3.1.1.2. Spectrophotometers
3.1.1.2.1. Flow Cytometers
3.1.1.2.2. Hemocytometers
3.1.1.2.3. Automated Cell Counters
3.1.1.2.4. Microscopes
3.1.1.2.5. Others
3.1.1.3. Cell Counting Consumables & Accessories
3.1.1.3.1. Reagents
3.1.1.3.2. Microplates
3.1.1.3.3. Others
3.2. Global Cell Counting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Cell Counting for Complete Blood Count
3.2.1.1.1. Automated Cell Counters
3.2.1.1.2. Manual Cell Counters
3.2.1.2. Cell Counting for Stem Cell Research
3.2.1.3. Cell Counting for Cell Based Therapeutics
3.2.1.4. Cell Counting for Bioprocessing
3.2.1.5. Cell Counting for Toxicology
3.2.1.6. Others
3.3. Global Cell Counting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Global Cell Counting in Hospitals & Diagnostic Laboratories
3.3.1.2. Global Cell Counting in Research & Academic Institutes
3.3.1.3. Global Cell Counting in Pharmaceutical & Biotechnology Companies
3.3.1.4. Others
3.4. Global Cell Counting Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Cell Counting Market Outlook, 2018 - 2031
4.1. North America Cell Counting Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Spectrophotometers
4.1.1.1.1. Flow Cytometers
4.1.1.1.2. Hemocytometers
4.1.1.1.3. Automated Cell Counters
4.1.1.1.4. Microscopes
4.1.1.1.5. Others
4.1.1.2. Cell Counting Consumables & Accessories
4.1.1.2.1. Reagents
4.1.1.2.2. Microplates
4.1.1.2.3. Others
4.2. North America Cell Counting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Cell Counting for Complete Blood Count
4.2.1.1.1. Automated Cell Counters
4.2.1.1.2. Manual Cell Counters
4.2.1.2. Cell Counting for Stem Cell Research
4.2.1.3. Cell Counting for Cell Based Therapeutics
4.2.1.4. Cell Counting for Bioprocessing
4.2.1.5. Cell Counting for Toxicology
4.2.1.6. Others
4.3. North America Cell Counting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Global Cell Counting in Hospitals & Diagnostic Laboratories
4.3.1.2. Global Cell Counting in Research & Academic Institutes
4.3.1.3. Global Cell Counting in Pharmaceutical & Biotechnology Companies
4.3.1.4. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Cell Counting Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
4.4.1.2. U.S. Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
4.4.1.3. U.S. Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
4.4.1.4. Canada Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
4.4.1.5. Canada Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
4.4.1.6. Canada Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Cell Counting Market Outlook, 2018 - 2031
5.1. Europe Cell Counting Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Spectrophotometers
5.1.1.1.1. Flow Cytometers
5.1.1.1.2. Hemocytometers
5.1.1.1.3. Automated Cell Counters
5.1.1.1.4. Microscopes
5.1.1.1.5. Others
5.1.1.2. Cell Counting Consumables & Accessories
5.1.1.2.1. Reagents
5.1.1.2.2. Microplates
5.1.1.2.3. Others
5.2. Europe Cell Counting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Cell Counting for Complete Blood Count
5.2.1.1.1. Automated Cell Counters
5.2.1.1.2. Manual Cell Counters
5.2.1.2. Cell Counting for Stem Cell Research
5.2.1.3. Cell Counting for Cell Based Therapeutics
5.2.1.4. Cell Counting for Bioprocessing
5.2.1.5. Cell Counting for Toxicology
5.2.1.6. Others
5.3. Europe Cell Counting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Global Cell Counting in Hospitals & Diagnostic Laboratories
5.3.1.2. Global Cell Counting in Research & Academic Institutes
5.3.1.3. Global Cell Counting in Pharmaceutical & Biotechnology Companies
5.3.1.4. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Cell Counting Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.2. Germany Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.3. Germany Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.4. U.K. Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.5. U.K. Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.6. U.K. Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.7. France Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.8. France Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.9. France Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.10. Italy Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.11. Italy Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.12. Italy Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.13. Turkey Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.14. Turkey Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.15. Turkey Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.16. Russia Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.17. Russia Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.18. Russia Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.19. Rest of Europe Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.20. Rest of Europe Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.21. Rest of Europe Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Cell Counting Market Outlook, 2018 - 2031
6.1. Asia Pacific Cell Counting Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Spectrophotometers
6.1.1.1.1. Flow Cytometers
6.1.1.1.2. Hemocytometers
6.1.1.1.3. Automated Cell Counters
6.1.1.1.4. Microscopes
6.1.1.1.5. Others
6.1.1.2. Cell Counting Consumables & Accessories
6.1.1.2.1. Reagents
6.1.1.2.2. Microplates
6.1.1.2.3. Others
6.2. Asia Pacific Cell Counting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Cell Counting for Complete Blood Count
6.2.1.1.1. Automated Cell Counters
6.2.1.1.2. Manual Cell Counters
6.2.1.2. Cell Counting for Stem Cell Research
6.2.1.3. Cell Counting for Cell Based Therapeutics
6.2.1.4. Cell Counting for Bioprocessing
6.2.1.5. Cell Counting for Toxicology
6.2.1.6. Others
6.3. Asia Pacific Cell Counting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Global Cell Counting in Hospitals & Diagnostic Laboratories
6.3.1.2. Global Cell Counting in Research & Academic Institutes
6.3.1.3. Global Cell Counting in Pharmaceutical & Biotechnology Companies
6.3.1.4. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Cell Counting Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.2. China Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.3. China Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.4. Japan Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.5. Japan Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.6. Japan Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.7. South Korea Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.8. South Korea Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.9. South Korea Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.10. India Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.11. India Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.12. India Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.13. Southeast Asia Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.14. Southeast Asia Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.15. Southeast Asia Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Cell Counting Market Outlook, 2018 - 2031
7.1. Latin America Cell Counting Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Spectrophotometers
7.1.1.1.1. Flow Cytometers
7.1.1.1.2. Hemocytometers
7.1.1.1.3. Automated Cell Counters
7.1.1.1.4. Microscopes
7.1.1.1.5. Others
7.1.1.2. Cell Counting Consumables & Accessories
7.1.1.2.1. Reagents
7.1.1.2.2. Microplates
7.1.1.2.3. Others
7.2. Latin America Cell Counting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
7.2.1.1. Cell Counting for Complete Blood Count
7.2.1.1.1. Automated Cell Counters
7.2.1.1.2. Manual Cell Counters
7.2.1.2. Cell Counting for Stem Cell Research
7.2.1.3. Cell Counting for Cell Based Therapeutics
7.2.1.4. Cell Counting for Bioprocessing
7.2.1.5. Cell Counting for Toxicology
7.2.1.6. Others
7.3. Latin America Cell Counting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Global Cell Counting in Hospitals & Diagnostic Laboratories
7.3.1.2. Global Cell Counting in Research & Academic Institutes
7.3.1.3. Global Cell Counting in Pharmaceutical & Biotechnology Companies
7.3.1.4. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Cell Counting Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.2. Brazil Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
7.4.1.3. Brazil Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.4. Mexico Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.5. Mexico Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
7.4.1.6. Mexico Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.7. Argentina Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.8. Argentina Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
7.4.1.9. Argentina Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.10. Rest of Latin America Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.11. Rest of Latin America Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
7.4.1.12. Rest of Latin America Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Cell Counting Market Outlook, 2018 - 2031
8.1. Middle East & Africa Cell Counting Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Spectrophotometers
8.1.1.1.1. Flow Cytometers
8.1.1.1.2. Hemocytometers
8.1.1.1.3. Automated Cell Counters
8.1.1.1.4. Microscopes
8.1.1.1.5. Others
8.1.1.2. Cell Counting Consumables & Accessories
8.1.1.2.1. Reagents
8.1.1.2.2. Microplates
8.1.1.2.3. Others
8.2. Middle East & Africa Cell Counting Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Cell Counting for Complete Blood Count
8.2.1.1.1. Automated Cell Counters
8.2.1.1.2. Manual Cell Counters
8.2.1.2. Cell Counting for Stem Cell Research
8.2.1.3. Cell Counting for Cell Based Therapeutics
8.2.1.4. Cell Counting for Bioprocessing
8.2.1.5. Cell Counting for Toxicology
8.2.1.6. Others
8.3. Middle East & Africa Cell Counting Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Global Cell Counting in Hospitals & Diagnostic Laboratories
8.3.1.2. Global Cell Counting in Research & Academic Institutes
8.3.1.3. Global Cell Counting in Pharmaceutical & Biotechnology Companies
8.3.1.4. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Cell Counting Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.2. GCC Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
8.4.1.3. GCC Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.4. South Africa Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.5. South Africa Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
8.4.1.6. South Africa Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.7. Egypt Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.8. Egypt Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
8.4.1.9. Egypt Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.10. Nigeria Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.11. Nigeria Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
8.4.1.12. Nigeria Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Cell Counting Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Cell Counting Market by Application, Value (US$ Bn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Cell Counting Market by End User, Value (US$ Bn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Distribution Channel vs by Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. ThermoFisher Scientific, Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Merck KGaA
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Agilent Technologies
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. PerkinElmer, Inc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. BD
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Danaher
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Bio-Rad Laboratories, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. BioTek Instruments, Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. GE Healthcare
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. DeNovix Inc.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ThermoFisher Scientific, Inc.
  • Merck KGaA
  • Agilent Technologies
  • PerkinElmer, Inc.
  • BD
  • Danaher
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • GE Healthcare
  • DeNovix Inc.

Methodology

Loading
LOADING...